Cargando…

Protease-activated receptor-2 ligands reveal orthosteric and allosteric mechanisms of receptor inhibition

Protease-activated receptor-2 (PAR2) has been implicated in multiple pathophysiologies but drug discovery is challenging due to low small molecule tractability and a complex activation mechanism. Here we report the pharmacological profiling of a potent new agonist, suggested by molecular modelling t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kennedy, Amanda J., Sundström, Linda, Geschwindner, Stefan, Poon, Eunice K. Y., Jiang, Yuhong, Chen, Rongfeng, Cooke, Rob, Johnstone, Shawn, Madin, Andrew, Lim, Junxian, Liu, Qingqi, Lohman, Rink-Jan, Nordqvist, Anneli, Fridén-Saxin, Maria, Yang, Wenzhen, Brown, Dean G., Fairlie, David P., Dekker, Niek
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7747594/ https://www.ncbi.nlm.nih.gov/pubmed/33335291 http://dx.doi.org/10.1038/s42003-020-01504-0

Ejemplares similares

Orthosteric and Allosteric Ligands of Nicotinic Acetylcholine Receptors for Smoking Cessation
por: Mohamed, Tasnim S., et al.
Publicado: (2015)

Structure of CC Chemokine Receptor 2 with Orthosteric and Allosteric Antagonists
por: Zheng, Yi, et al.
Publicado: (2016)

Differential regulation of muscarinic M(1 )receptors by orthosteric and allosteric ligands
por: Davis, Christopher N, et al.
Publicado: (2009)

Orthosteric and/or Allosteric Binding of α-Conotoxins to Nicotinic Acetylcholine Receptors and Their Models
por: Kryukova, Elena V., et al.
Publicado: (2018)

Internalization of the chemokine receptor CCR4 can be evoked by orthosteric and allosteric receptor antagonists
por: Ajram, Laura, et al.
Publicado: (2014)

New Insights into Bitopic Orthosteric/Allosteric Ligands of Cannabinoid Receptor Type 2
por: Ferrisi, Rebecca, et al.
Publicado: (2023)

Bitopic ligands: all-in-one orthosteric and allosteric
por: Kamal, Maud, et al.
Publicado: (2009)

Orthosteric and Allosteric Dual Targeting of the Nuclear Receptor RORγt with a Bitopic Ligand
por: Meijer, Femke A., et al.
Publicado: (2021)

Molecular Modeling Study of a Receptor–Orthosteric Ligand–Allosteric Modulator Signaling Complex
por: Jiang, Chen, et al.
Publicado: (2023)

Orthosteric ligand selectivity and allosteric probe dependence at Hydroxycarboxylic acid receptor HCAR2
por: Cheng, Lin, et al.
Publicado: (2023)

FRET-Based Detection of M(1) Muscarinic Acetylcholine Receptor Activation by Orthosteric and Allosteric Agonists
por: Markovic, Danijela, et al.
Publicado: (2012)

Contrasting Properties of α7-Selective Orthosteric and Allosteric Agonists Examined on Native Nicotinic Acetylcholine Receptors
por: Gill, JasKiran K., et al.
Publicado: (2013)

Activation of the Rat α1β2ε GABA(A) Receptor by Orthosteric and Allosteric Agonists
por: Germann, Allison L., et al.
Publicado: (2022)

5-HT(2C) Receptor Stimulation in Obesity Treatment: Orthosteric Agonists vs. Allosteric Modulators
por: Przegaliński, Edmund, et al.
Publicado: (2023)

Allosteric Modulation of the CB1 Cannabinoid Receptor by Cannabidiol—A Molecular Modeling Study of the N-Terminal Domain and the Allosteric-Orthosteric Coupling
por: Jakowiecki, Jakub, et al.
Publicado: (2021)

Analysis of equilibrium binding of an orthosteric tracer and two allosteric modulators
por: Jakubík, Jan, et al.
Publicado: (2019)

Orthosteric and allosteric modulation of human HCAR2 signaling complex
por: Mao, Chunyou, et al.
Publicado: (2023)

Orthosteric- versus allosteric-dependent activation of the GABA(A) receptor requires numerically distinct subunit level rearrangements
por: Amin, Jahanshah, et al.
Publicado: (2017)

Cooperativity between the orthosteric and allosteric ligand binding sites of RORγt
por: de Vries, Rens M. J. M., et al.
Publicado: (2021)

Design, synthesis and biological evaluation of novel orthosteric-allosteric ligands of the cannabinoid receptor type 2 (CB(2)R)
por: Ferrisi, Rebecca, et al.
Publicado: (2022)

On-target and off-target effects of novel orthosteric and allosteric activators of GPR84
por: Mancini, Sarah J., et al.
Publicado: (2019)

Orthosteric–allosteric dual inhibitors of PfHT1 as selective antimalarial agents
por: Huang, Jian, et al.
Publicado: (2021)

Design, Synthesis, and Biological Activity of New CB2 Receptor Ligands: from Orthosteric and Allosteric Modulators to Dualsteric/Bitopic Ligands
por: Gado, Francesca, et al.
Publicado: (2022)

In Silico Methods for the Discovery of Orthosteric GABA(B) Receptor Compounds
por: Evenseth, Linn M., et al.
Publicado: (2019)

The Effects of Separate and Combined Treatment of Male Rats with Type 2 Diabetes with Metformin and Orthosteric and Allosteric Agonists of Luteinizing Hormone Receptor on Steroidogenesis and Spermatogenesis
por: Bakhtyukov, Andrey A., et al.
Publicado: (2021)

Xanomeline displays concomitant orthosteric and allosteric binding modes at the M(4) mAChR
por: Burger, Wessel A. C., et al.
Publicado: (2023)

Full-length human GLP-1 receptor structure without orthosteric ligands
por: Wu, Fan, et al.
Publicado: (2020)

Controlling opioid receptor functional selectivity by targeting distinct subpockets of the orthosteric site
por: Uprety, Rajendra, et al.
Publicado: (2021)

The Role of Orthosteric Building Blocks of Bitopic Ligands for Muscarinic M1 Receptors
por: Volpato, Daniela, et al.
Publicado: (2020)

Allosterism vs. Orthosterism: Recent Findings and Future Perspectives on A(2B) AR Physio-Pathological Implications
por: Barresi, Elisabetta, et al.
Publicado: (2021)

Positive Allosteric Modulation of CB1 and CB2 Cannabinoid Receptors Enhances the Neuroprotective Activity of a Dual CB1R/CB2R Orthosteric Agonist
por: Polini, Beatrice, et al.
Publicado: (2020)

Predicting Allosteric Effects from Orthosteric Binding in Hsp90-Ligand Interactions: Implications for Fragment-Based Drug Design
por: Chandramohan, Arun, et al.
Publicado: (2016)

Mechanistic Insights Into Co-Administration of Allosteric and Orthosteric Drugs to Overcome Drug-Resistance in T315I BCR-ABL1
por: Zhang, Hao, et al.
Publicado: (2022)

Discovery of a new class of orthosteric antagonists with nanomolar potency at extrasynaptic GABA(A) receptors
por: Falk-Petersen, Christina Birkedahl, et al.
Publicado: (2020)

Modeling the Orthosteric Binding Site of the G Protein-Coupled Odorant Receptor OR5K1
por: Nicoli, Alessandro, et al.
Publicado: (2023)

Sterol derivative binding to the orthosteric site causes conformational changes in an invertebrate Cys-loop receptor
por: De Gieter, Steven, et al.
Publicado: (2023)

An Orthosteric Inhibitor of the Ras-Sos Interaction
por: Patgiri, Anupam, et al.
Publicado: (2011)

Discovery of Potential Orthosteric and Allosteric Antagonists of P2Y1R from Chinese Herbs by Molecular Simulation Methods
por: Zhang, Xu, et al.
Publicado: (2016)

Makaluvamine G from the Marine Sponge Zyzzia fuliginosa Inhibits Muscle nAChR by Binding at the Orthosteric and Allosteric Sites
por: Kudryavtsev, Denis S., et al.
Publicado: (2018)

Inhibition of low-density lipoprotein receptor degradation with a cyclic peptide that disrupts the homodimerization of IDOL E3 ubiquitin ligase
por: Leitch, Eilidh K., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_081r67ur7qsv5f6cd2s4om2v90